Chemotherapy-related cognitive impairment (CRCI), and neurotransmitter signaling, longevity, and inflammation pathways in 366 breast cancer (BC) patients and 366 age-matched cancer-free controls: A prospective, nationwide, longitudinal URCC NCORP study Meeting Abstract


Authors: Janelsins, M. C.; Yao, S.; Mustian, K. M.; Peppone, L. J.; Heckler, C. E.; Esparaz, B.; Giguere, J. K.; Irwin, R.; Neilan, B.; Ahles, T.; Ambrosone, C. B.; Morrow, G. R.
Abstract Title: Chemotherapy-related cognitive impairment (CRCI), and neurotransmitter signaling, longevity, and inflammation pathways in 366 breast cancer (BC) patients and 366 age-matched cancer-free controls: A prospective, nationwide, longitudinal URCC NCORP study
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901992
PROVIDER: wos
Notes: Meeting Abstract: 9503 -- Source: Wos
MSK Authors
  1. Tim A Ahles
    95 Ahles
Related MSK Work